# OnCo record lgals9 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/lgals9/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "lgals9" ;
  schema:name "Galectin-9 (LGALS9)"@en ;
  schema:alternateName "galectin 9"@en, "Gal-9"@en, "LGALS9A"@en, "LGALS9" ;
  schema:description "Galectin-9 is a sugar-binding protein that presses TIM-3 on T cells and can kill the helper T cells that carry it. Tumour blood vessels make more of it than normal ones."@en ;
  schema:url <https://onco.cc/targets/lgals9/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6570>, <https://www.uniprot.org/uniprotkb/O00182/entry>, <https://www.ncbi.nlm.nih.gov/gene/3965> ;
  onco:tag "checkpoint-map" ;
  onco:targetClass "checkpoint" ;
  schema:sameAs <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6570>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000168961>, <https://www.uniprot.org/uniprotkb/O00182/entry>, <https://www.ncbi.nlm.nih.gov/gene/3965> ;
  onco:related <https://onco.cc/targets/tim3/>, <https://onco.cc/targets/ceacam1/>, <https://onco.cc/drugs/cobolimab/> ;
  onco:technologies <https://onco.cc/technologies/tim3-blockade/> ;
  onco:pathways <https://onco.cc/pathways/t-cell-exhaustion/> .